glp-1 business lifetime.life is betting on the gym-as-clinic model. During its latest earnings call, CEO Bahram Akradi described how the company's MIORA longevity clinics are approaching weight-loss medications, saying: “We're telling people, come in GLP-1 Drugs Market Size to

Understanding the relationship between tirzepatide and emotional symptoms requires examining clinical evidence, potential indirect mechanisms, and individual patient factors that may influence mood during treatment

While these observed shifts provide important learnings for brands and retailers, businesses need more information to better anticipate where and whom these shifts will come from in the future

provides patients with clear guidance using experienced medical advice and structured plans

Anti-obesity therapy for cardiovascular disease prevention: potential expected roles of glucagon-like peptide-1 receptor agonists

GLP-1 agonists effect on augmenting fibrinolytic potential